Your session is about to expire
← Back to Search
Dexmedetomidine for Congenital Heart Disease
Study Summary
This trial is testing whether different anesthetics can help reduce stress and improve outcomes for children undergoing heart surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 798 Patients • NCT02004613Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with Autism Spectrum Disorder (ASD).I have had heart surgery to correct a defect with a left to right blood flow issue.I have been diagnosed with atrioventricular septal defect (AVSD).I have been diagnosed with a ventricular septal defect (VSD).I have been diagnosed with Tetralogy of Fallot (TOF).I have AVSD and high blood pressure in my lungs.My child needs heart surgery for a serious condition and is under 1 year old.
- Group 1: Dexmedetomidine
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this test only consider young adults?
"This clinical trial includes infants that are one month old up to 12 months old."
How many people have been chosen to participate in this clinical trial?
"This particular study is no longer recruiting patients, with the most recent update having been on February 9th, 2022. However, there are 361 other trials for heart defects and 118 for Dexmedetomidine that are still looking for volunteers."
Are there any slots left for potential participants in this experiment?
"This particular trial, which was published on May 1st 2014 and updated February 9th 2022, is not currently looking for new patients. It's worth noting that 479 other studies are actively recruiting participants."
Has the FDA greenlit Dexmedetomidine for public consumption?
"Given that this is a phase 2 trial (meaning there is some data supporting safety but none supporting efficacy), our team at Power have given Dexmedetomidine a score of 2 for safety."
Is there a body of research to support the use of Dexmedetomidine?
"This medication is being studied in 118 ongoing clinical trials, with 25 of them being in the third and final stage. Most of these trials are taking place in Karachi, Sindh; however, there are 222 locations total running Dexmedetomidine studies."
To what extent is Dexmedetomidine effective?
"Originally designed as a treatment for disorders, dexmedetomidine is also used to help patients who require ventilation, have intubation issues, or suffer from cyclic vomiting syndrome."
How can I sign up to help with this research?
"Investigators are looking to enroll 30 infants that have had congenital heart defects repaired with a left-to-right shunt. The patients must be between 1 month and 12 months old to participate."
Share this study with friends
Copy Link
Messenger